Role of DISC1 in neural development and schizophrenia

Current Opinion in Neurobiology

Volumn 17, Issue 1, 2007, Pages 95-102

  Mackie, Shaun ^a   Millar, J Kirsty ^a   Porteous, David J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; DISC1 PROTEIN; FEZ1 PROTEIN; NDEL1 PROTEIN; NERVE PROTEIN; NEUROLEPTIC AGENT; NICOTINE; PHOSPHODIESTERASE; PHOSPHODIESTERASE IV; UNCLASSIFIED DRUG;

DISEASE PREDISPOSITION; GENETIC ANALYSIS; GENETIC RISK; MOOD DISORDER; NERVE CELL DIFFERENTIATION; NERVE GROWTH; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ANIMALS; BRAIN; CARRIER PROTEINS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MODELS, NEUROLOGICAL; NERVE TISSUE PROTEINS; SCHIZOPHRENIA; TUMOR SUPPRESSOR PROTEINS;

EID: 33846873634     PISSN: 09594388     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.conb.2007.01.007     Document Type: Review

References (62)

1. Jablensky A. Subtyping schizophrenia: implications for genetic research. Mol Psychiatry 11 (2006) 815-836
2. Gottesman I.I. Schizophrenia Genesis; The Origins of Madness (1991), WH Freeman & Co, New York
3. Rapoport J.L., Addington A.M., Frangou S., and Psych M.R. The neurodevelopmental model of schizophrenia: update 2005. Mol Psychiatry 10 (2005) 434-449
4. Job D.E., Whalley H.C., Johnstone E.C., and Lawrie S.M. Grey matter changes over time in high risk subjects developing schizophrenia. NeuroImage 25 (2005) 1023-1030
5. Thompson P.M., Vidal C., Giedd J.N., Gochman P., Blumenthal J., Nicolson R., Toga A.W., and Rapoport J.L. Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proc Natl Acad Sci USA 98 (2001) 11650-11655
6. Harrison P.J., and Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 10 (2005) 40-68
7. Hennah W., Thomson P., Peltonen L., and Porteous D. Genes and schizophrenia: beyond schizophrenia: the role of DISC1 in major mental illness. Schizophr Bull 32 (2006) 409-416
8. Porteous D.J., and Millar J.K. Disrupted in schizophrenia 1: building brains and memories. Trends Mol Med 12 (2006) 255-261
9. Carter C.J. Schizophrenia susceptibility genes converge on interlinked pathways related to glutamatergic transmission and long-term potentiation, oxidative stress and oligodendrocyte viability. Schizophr Res 86 (2006) 1-14
10. Millar J.K., Wilson-Annan J.C., Anderson S., Christie S., Taylor M.S., Semple C.A., Devon R.S., Clair D.M., Muir W.J., Blackwood D.H., et al. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet 9 (2000) 1415-1423
11. Blackwood D.H., Fordyce A., Walker M.T., St Clair D.M., Porteous D.J., and Muir W.J. Schizophrenia and affective disorders - cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. Am J Hum Genet 69 (2001) 428-433
12. Cannon T.D., Hennah W., van Erp T.G., Thompson P.M., Lonnqvist J., Huttunen M., Gasperoni T., Tuulio-Henriksson A., Pirkola T., Toga A.W., et al. Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short- and long-term memory. Arch Gen Psychiatry 62 (2005) 1205-1213. The first twin study model that persuasively links DISC1 haplotypes to quantitative measures of cognition and neuroanatomical changes in the prefrontal cortex.
13. Hennah W., Tuulio-Henriksson A., Paunio T., Ekelund J., Varilo T., Partonen T., Cannon T.D., Lonnqvist J., and Peltonen L. A haplotype within the DISC1 gene is associated with visual memory functions in families with a high density of schizophrenia. Mol Psychiatry 10 (2005) 1097-1103
14. Burdick K.E., Hodgkinson C.A., Szeszko P.R., Lencz T., Ekholm J.M., Kane J.M., Goldman D., and Malhotra A.K. DISC1 and neurocognitive function in schizophrenia. NeuroReport 16 (2005) 1399-1402
15. Callicott J.H., Straub R.E., Pezawas L., Egan M.F., Mattay V.S., Hariri A.R., Verchinski B.A., Meyer-Lindenberg A., Balkissoon R., Kolachana B., et al. Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proc Natl Acad Sci USA 102 (2005) 8627-8632. The first study showing a strong correlation between DISC1 genotype and brain structure and function using functional magnetic resonance imaging.
16. Thomson P.A., Harris S.E., Starr J.M., Whalley L.J., Porteous D.J., and Deary I.J. Association between genotype at an exonic SNP in DISC1 and normal cognitive aging. Neurosci Lett 389 (2005) 41-45
17. Hashimoto R., Numakawa T., Ohnishi T., Kumamaru E., Yagasaki Y., Ishimoto T., Mori T., Nemoto K., Adachi N., Izumi A., et al. Impact of the DISC1 Ser704Cys polymorphism on risk for major depression, brain morphology, and ERK signaling. Hum Mol Genet 15 (2006) 3024-3033
18. Millar J.K., Pickard B.S., Mackie S., James R., Christie S., Buchanan S.R., Malloy M.P., Chubb J.E., Huston E., Baillie G.S., et al. DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling. Science 310 (2005) 1187-1191. These authors show that the DISC1 protein modulates cellular cAMP signalling through physical interaction with the phosphodiesterase PDE4B. Because PDE4s have previously been implicated in learning, memory and mood disorders, perturbation of this pathway is implicated in the phenotypic overlap between psychotic and affective disorders. Moreover, expression levels are reduced by 50% in patient cells lines carrying DISC1 or PDE4B chromosomal disruptions, favouring a model of pathophysiology based on a haploinsufficiency mechanism.
19. Maeda K., Nwulia E., Chang J., Balkissoon R., Ishizuka K., Chen H., Zandi P., McInnis M.G., and Sawa A. Differential expression of Disrupted-in-Schizophrenia (DISC1) in bipolar disorder. Biol Psychiatry 60 (2006) 929-935
20. Millar J.K., James R., Brandon N.J., and Thomson P.A. DISC1 and DISC2: discovering and dissecting molecular mechanisms underlying psychiatric illness. Ann Med 36 (2004) 367-378
21. Ishizuka K., Paek M., Kamiya A., and Sawa A. A review of Disrupted-In-Schizophrenia-1 (DISC1): neurodevelopment, cognition, and mental conditions. Biol Psychiatry 59 (2006) 1189-1197
22. Austin C.P., Ky B., Ma L., Morris J.A., and Shughrue P.J. Expression of Disrupted-In-Schizophrenia-1, a schizophrenia-associated gene, is prominent in the mouse hippocampus throughout brain development. Neuroscience 124 (2004) 3-10
23. Schurov I.L., Handford E.J., Brandon N.J., and Whiting P.J. Expression of disrupted in schizophrenia 1 (DISC1) protein in the adult and developing mouse brain indicates its role in neurodevelopment. Mol Psychiatry 9 (2004) 1100-1110
24. Bloom L., and Horvitz H.R. The Caenorhabditis elegans gene unc-76 and its human homologs define a new gene family involved in axonal outgrowth and fasciculation. Proc Natl Acad Sci USA 94 (1997) 3414-3419
25. Fujita T., Ikuta J., Hamada J., Okajima T., Tatematsu K., Tanizawa K., and Kuroda S. Identification of a tissue-non-specific homologue of axonal fasciculation and elongation protein ζ-1. Biochem Biophys Res Commun 313 (2004) 738-744
26. Honda A., Miyoshi K., Baba K., Taniguchi M., Koyama Y., Kuroda S., Katayama T., and Tohyama M. Expression of fasciculation and elongation protein ζ-1 (FEZ1) in the developing rat brain. Brain Res Mol Brain Res 122 (2004) 89-92
27. Miyoshi K., Honda A., Baba K., Taniguchi M., Oono K., Fujita T., Kuroda S., and Katayama T. Tohyama M: Disrupted-In-Schizophrenia 1, a candidate gene for schizophrenia, participates in neurite outgrowth. Mol Psychiatry 8 (2003) 685-694
28. Kamiya A., Kubo K., Tomoda T., Takaki M., Youn R., Ozeki Y., Sawamura N., Park U., Kudo C., Okawa M., et al. A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development. Nat Cell Biol 7 (2005) 1167-1178. DISC1 is shown to be associated with a microtubule-associated dynein motor protein complex and is essential for maintaining this complex at the centrosome. Using an in utero gene transfer technique and RNA interference, the authors also demonstrate that inhibiting DISC1 function in mice causes abnormal development of the cerebral cortex through a mechanism that perturbs correct neuronal migration.
29. Ozeki Y., Tomoda T., Kleiderlein J., Kamiya A., Bord L., Fujii K., Okawa M., Yamada N., Hatten M.E., Snyder S.H., et al. Disrupted-in-Schizophrenia-1 (DISC-1): mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth. Proc Natl Acad Sci USA 100 (2003) 289-294
30. Morris J.A., Kandpal G., Ma L., and Austin C.P. DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation. Hum Mol Genet 12 (2003) 1591-1608
31. Brandon N.J., Handford E.J., Schurov I., Rain J.C., Pelling M., Duran-Jimeniz B., Camargo L.M., Oliver K.R., Beher D., Shearman M.S., et al. Disrupted in Schizophrenia 1 and Nudel form a neurodevelopmentally regulated protein complex: implications for schizophrenia and other major neurological disorders. Mol Cell Neurosci 25 (2004) 42-55
32. Sasaki S., Shionoya A., Ishida M., Gambello M.J., Yingling J., Wynshaw-Boris A., and Hirotsune S. A LIS1/NUDEL/cytoplasmic dynein heavy chain complex in the developing and adult nervous system. Neuron 28 (2000) 681-696
33. Feng Y., Olson E.C., Stukenberg P.T., Flanagan L.A., Kirschner M.W., and Walsh C.A. LIS1 regulates CNS lamination by interacting with mNudE, a central component of the centrosome. Neuron 28 (2000) 665-679
34. Shu T., Ayala R., Nguyen M.D., Xie Z., Gleeson J.G., and Tsai L.H. Ndel1 operates in a common pathway with LIS1 and cytoplasmic dynein to regulate cortical neuronal positioning. Neuron 44 (2004) 263-277
35. Sasaki S., Mori D., Toyo-oka K., Chen A., Garrett-Beal L., Muramatsu M., Miyagawa S., Hiraiwa N., Yoshiki A., Wynshaw-Boris A., et al. Complete loss of Ndel1 results in neuronal migration defects and early embryonic lethality. Mol Cell Biol 25 (2005) 7812-7827
36. Hayashi M.A., Portaro F.C., Bastos M.F., Guerreiro J.R., Oliveira V., Gorrao S.S., Tambourgi D.V., Sant'Anna O.A., Whiting P.J., Camargo L.M., et al. Inhibition of NUDEL (nuclear distribution element-like)-oligopeptidase activity by disrupted-in-schizophrenia 1. Proc Natl Acad Sci USA 102 (2005) 3828-3833. This study reminds us that NDEL1 has an enzymatic endo-oligopeptidase activity, which might be distinct from its role in neuronal migration during early development, but is likewise regulated by DISC1.
37. Lipska B.K., Peters T., Hyde T.M., Halim N., Horowitz C., Mitkus S., Weickert C.S., Matsumoto M., Sawa A., Straub R.E., et al. Expression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs. Hum Mol Genet 15 (2006) 1245-1258
38. Davis R.L., Cherry J., Dauwalder B., Han P.L., and Skoulakis E. The cyclic AMP system and Drosophila learning. Mol Cell Biochem 149-150 (1995) 271-278
39. Houslay M.D., Schafer P., and Zhang K.Y. Keynote review: phosphodiesterase-4 as a therapeutic target. Drug Discov Today 10 (2005) 1503-1519
40. O'Donnell J.M., and Zhang H.T. Antidepressant effects of inhibitors of cAMP phosphodiesterase (PDE4). Trends Pharmacol Sci 25 (2004) 158-163
41. Zhang H.T., Huang Y., Jin S.L., Frith S.A., Suvarna N., Conti M., and O'Donnell J.M. Antidepressant-like profile and reduced sensitivity to rolipram in mice deficient in the PDE4D phosphodiesterase enzyme. Neuropsychopharmacology 27 (2002) 587-595
42. Giorgi M., Modica A., Pompili A., Pacitti C., and Gasbarri A. The induction of cyclic nucleotide phosphodiesterase 4 gene (PDE4D) impairs memory in a water maze task. Behav Brain Res 154 (2004) 99-106
43. Zhang H.T., Zhao Y., Huang Y., Dorairaj N.R., Chandler L.J., and O'Donnell J.M. Inhibition of the phosphodiesterase 4 (PDE4) enzyme reverses memory deficits produced by infusion of the MEK inhibitor U0126 into the CA1 subregion of the rat hippocampus. Neuropsychopharmacology 29 (2004) 1432-1439
44. Zhang H.T., Huang Y., Suvarna N.U., Deng C., Crissman A.M., Hopper A.T., De Vivo M., Rose G.M., and O'Donnell J.M. Effects of the novel PDE4 inhibitors MEM1018 and MEM1091 on memory in the radial-arm maze and inhibitory avoidance tests in rats. Psychopharmacology (Berl) 179 (2005) 613-619
45. Maxwell C.R., Kanes S.J., Abel T., and Siegel S.J. Phosphodiesterase inhibitors: a novel mechanism for receptor-independent antipsychotic medications. Neuroscience 129 (2004) 101-107
46. Baillie G.S., MacKenzie S.J., McPhee I., and Houslay M.D. Sub-family selective actions in the ability of Erk2 MAP kinase to phosphorylate and regulate the activity of PDE4 cyclic AMP-specific phosphodiesterases. Br J Pharmacol 131 (2000) 811-819
47. Hill E.V., Houslay M.D., and Baillie G.S. Investigation of extracellular signal-regulated kinase 2 mitogen-activated protein kinase phosphorylation and regulation of activity of PDE4 cyclic adenosine monophosphate-specific phosphodiesterases. Methods Mol Biol 307 (2005) 225-237
48. Chiba S., Hashimoto R., Hattori S., Yohda M., Lipska B., Weinberger D.R., and Kunugi H. Effect of antipsychotic drugs on DISC1 and dysbindin expression in mouse frontal cortex and hippocampus. J Neural Transm 113 (2006) 1337-1346
49. Tardito D., Perez J., Tiraboschi E., Musazzi L., Racagni G., and Popoli M. Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview. Pharmacol Rev 58 (2006) 115-134
50. Duman C.H., Schlesinger L., Kodama M., Russell D.S., and Duman R.S. A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment. Biol Psychiatry (2006) 10.1016/j.biopsych.2006.05
51. Pickard BS, Thomson PA, Christoforou A, Evans KL, Morris SW, Porteous DJ, Blackwood DHR, Muir WJ: The PDE4B gene confers sex-specific protection against schizophrenia. Psychiatr Genet 2007, in press.
52. Polesskaya O.O., Smith R.F., and Fryxell K.J. Chronic nicotine doses down-regulate PDE4 isoforms that are targets of antidepressants in adolescent female rats. Biol Psychiatry (2006) 10.1016/j.biopsych.2006.03.038
53. Gretarsdottir S., Thorleifsson G., Reynisdottir S.T., Manolescu A., Jonsdottir S., Jonsdottir T., Gudmundsdottir T., Bjarnadottir S.M., Einarsson O.B., Gudjonsdottir H.M., et al. The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. Nat Genet 35 (2003) 131-138
54. Houslay M.D., and Adams D.R. PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization. Biochem J 370 (2003) 1-18
55. Takahashi M., Terwilliger R., Lane C., Mezes P.S., Conti M., and Duman R.S. Chronic antidepressant administration increases the expression of cAMP-specific phosphodiesterase 4A and 4B isoforms. J Neurosci 19 (1999) 610-618
56. D'Sa C., Eisch A.J., Bolger G.B., and Duman R.S. Differential expression and regulation of the cAMP-selective phosphodiesterase type 4A splice variants in rat brain by chronic antidepressant administration. Eur J Neurosci 22 (2005) 1463-1475
57. Dlaboga D., Hajjhussein H., and O'Donnell J.M. Regulation of phosphodiesterase-4 (PDE4) expression in mouse brain by repeated antidepressant treatment: comparison with rolipram. Brain Res 1096 (2006) 104-112
58. Kirkpatrick B., Xu L., Cascella N., Ozeki Y., Sawa A., and Roberts R.C. DISC1 immunoreactivity at the light and ultrastructural level in the human neocortex. J Comp Neurol 497 (2006) 436-450
59. Camargo L.M., Collura V., Rain J.C., Mizuguchi K., Hermjakob H., Kerrien S., Bonnert T.P., Whiting P.J., and Brandon N.J. Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia. Mol Psychiatr 12 (2007) 74-86
60. Shinoda T., Taya S., Tsuboi D., Hikita T., Matsuzawa R., Kuroda S., Iwamatsu A., and Kaibuchi K. DISC1 regulates neurotrophin-induced axon elongation via interaction with Grb2. J Neurosci 27 (2007) 4-14
61. Taya S., Shinoda T., Tsuboi D., Asaki J., Nagai K., Hikita T., Kuroda S., Kuroda K., Shimizu M., Hirotsune S., Iwamatsu A., and Kaibuchi K. DISC1 regulates the transport of the NUDEL/LIS1/14-3-3epsilon complex through kinesin-1. J Neurosci 27 (2007) 15-26
62. Hennah W., Tomppo L., Hiekkalinna T., Palo O.M., Kilpinen H., Ekelund J., Tuulio-Henriksson A., Silander K., Partonen T., Paunio T., Terwilliger J.D., Lonnqvist J., and Peltonen L. Families with the risk allele of DISC1 reveal a link between schizophrenia and another component of the same molecular pathway, NDE1. Hum Mol Genet (2006) 10.1093/hmg/ddl462